Ola Blixt, University of Copenhagen (image) University of Copenhagen Caption The world's most widespread test for ovarian cancer reports false-positives in 94 of 100 diagnosed cases. Adding a test for a certain sugar molecule could reduce the number of mistaken diagnosis by at least 50 percent finds Copenhagen Chemist Ola Blixt. Credit Foto: Jes Andersen/University of Copenhagen Usage Restrictions None Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.